ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 4.550
-0.200 (-4.21%)
At close: Mar 25, 2026
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 22.87 million as of March 25, 2026. Its market cap has increased by 34.63% in one year.
Market Cap
22.87M
Enterprise Value
22.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.55
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 22.87M, a decrease of -36.66%. That is a compound annual growth rate of -2.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 22.87M | -26.61% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ondine Biomedical | 55.85M |
| Faron Pharmaceuticals Oy | 49.79M |
| hVIVO | 46.61M |
| Poolbeg Pharma | 29.44M |
| Arecor Therapeutics | 25.67M |
| Sareum Holdings | 21.40M |
| Aptamer Group | 18.88M |
| SkinBioTherapeutics | 18.14M |